Endocyte Shares Up 48% Premarket; Following 157% Rally On Mon. Amid News Of Global License For PSMA-617, Shares Rose 20% After Hours; Wedbush Upgrade Tues. Morning Pushed Stock Up Another ~15%
Charles Gross